VIENNA ― At the European Society of Ophthalmology meeting, Susanne Binder, MD, discusses the latest advances in stem cell research to treat rare eye diseases. Several centers globally are using robust human-derived embryonic stem cells and skin-derived stem cells in their research.
A protein provides emergency aid
Small heat shock proteins ensure that other proteins do not clot, allowing the cell to survive stress.
Research and Markets: Corneal Graft Rejection – Pipeline Review, H1 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/pd5bj8/corneal_graft) has announced the addition of the “Corneal Graft Rejection – Pipeline Review, H1 2015” report to their offering. This report provides compre…
Research and Markets: Ocular Hypertension – Pipeline Review, H1 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/jrdqcj/ocular) has announced the addition of the “Ocular Hypertension – Pipeline Review, H1 2015” report to their offering. This report provides comprehensive inf…
Genetics of Inherited Eye Disease
Status: Not yet recruiting,
Condition Summary: Genetic Eye Disease
Some hospitals exceed Medicare-allowed costs by up to 1000%
Hospitals in the United States with the highest charge-to-cost ratios billed uninsured consumers and out-of-network patients more than 10 times the cost allowed by Medicare, according to recent study data.“There is no justification for these outrageous rates but no one tells hospitals they can’t charge them,” study researcher Gerard F. Anderson, PhD, a professor at the Johns Hopkins Bloomberg School of Public Health, said in a press release. “For the most part, there is no regulation of hospital rates and there are no market forces that force hospitals to lower (Read more...)